Generic placeholder image

Current Genomics


ISSN (Print): 1389-2029
ISSN (Online): 1875-5488

Challenges and Solutions in the Development of Genomic Biomarker Panels: A Systematic Phased Approach

Author(s): K. Shahzad, A. Fatima, M. Cadeiras, N. Wisniewski, G. Bondar, R. Cheng, E. Reed and M. C. Deng

Volume 13 , Issue 4 , 2012

Page: [334 - 341] Pages: 8

DOI: 10.2174/138920212800793339

Price: $65


In the post-genome era, high throughput gene expression profiling has been successfully used to develop genomic biomarker panels (GBP) that can be integrated into clinical decision making. The development of GBPs in the context of personalized medicine is a scientifically challenging and resource-intense process. It needs to be accomplished in a systematic phased approach to address biological variation related to a clinical phenotype (e.g. disease etiology, gender, etc.) and minimize technical variation (noise). Here we present the methodological aspects of GBP development based on the experience of the Cardiac Allograft Rejection Gene Expression Observation (CARGO) study, a study that lead to the development of a molecular classifier for rejection screening in heart transplant patients.

Keywords: Post-genome era, genomics, gene expression profiling, biomarker panels, molecular classifier, heart transplantation, multiorgan dysfunction, personalized medicine

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy